Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Journal: Nature Medicine

Published: 2021-02-08

DOI: 10.1038/s41591-021-01270-4

Affiliations: 7

Authors: 14

Go to article
Institutions Share
UTMB Health, United States of America (USA) 0.44
Pfizer Inc., United States of America (USA) 0.29
University of Texas Medical Branch (UTMB), United States of America (USA) 0.27

Return